合佳医药 (838641.OC)

+ 收藏

利润表(合佳医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 945,885,012.18404,586,068.28739,038,868.62392,136,414.08189,025,309.08
 营业收入(元) 945,885,012.18404,586,068.28739,038,868.62392,136,414.08189,025,309.08
二、营业总成本(元) 861,945,669.33373,149,404.49675,485,878.32352,584,395.22176,546,064.60
 营业成本(元) 739,552,470.46320,939,370.29577,083,500.47308,197,365.94145,452,691.51
 研发费用(元) 28,175,539.3911,993,577.3323,919,793.1213,089,711.397,119,800.80
 营业税金及附加(元) 5,452,239.692,328,085.953,524,092.131,397,842.31574,378.40
 销售费用(元) 9,930,649.634,464,195.146,939,830.034,376,627.139,838,266.61
 管理费用(元) 66,216,071.6329,927,175.2954,249,881.6320,973,793.5610,609,581.67
 财务费用(元) 12,618,698.533,497,000.499,768,780.944,549,054.892,951,345.61
  其中:利息费用(元) 15,266,102.117,102,000.2113,639,254.69-3,032,925.38
  其中:利息收入(元) 1,547,236.82805,391.5410,897,512.38--495,448.68
三、其他经营收益
 加:公允价值变动收益(元) -318,848.41----
 加:投资收益(元) 181,903.8321,068.7392,448.2926,365.3510,529.50
 资产减值损失(元) -619,758.36-855,839.48--
 信用减值损失(元) -4,666,202.671,537,079.687,916,893.44-2,739,170.10-
 其他收益(元) 7,322,229.323,044,245.461,487,571.83189,792.3268,194.26
四、营业利润(元) 85,838,666.5636,039,057.6673,905,743.3437,029,006.4312,557,968.24
 加:营业外收入(元) 147,994.7240,634.1160,574.720.570.54
 减:营业外支出(元) 542,618.3229,309.79659,463.571,513,517.411,485,538.10
五、利润总额(元) 85,444,042.9636,050,381.9873,306,854.4935,515,489.5911,072,430.68
 减:所得税费用(元) 13,892,341.965,032,201.5111,114,899.555,452,229.792,212,261.86
六、净利润(元) 71,551,701.0031,018,180.4762,191,954.9430,063,259.808,860,168.82
(一)按经营持续性分类
  持续经营净利润(元) 71,551,701.0031,018,180.47-30,063,259.808,860,168.82
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 72,297,002.0631,099,671.1062,171,379.9830,254,901.169,013,023.63
  少数股东损益(元) -745,301.06-81,490.6320,574.96-191,641.36-152,854.81
 扣除非经常性损益后的净利润(元) 66,241,472.5028,514,147.8362,775,240.4031,367,522.7710,214,110.15
七、每股收益
 一、基本每股收益(元) 0.440.210.450.220.07
 二、稀释每股收益(元) 0.440.210.450.220.07
八、其他综合收益(元) -76,174.43-26,708.7565,362.9325,675.68-40,849.31
 归属于母公司股东的其他综合收益(元) -76,174.39-26,708.7465,362.9025,675.67-40,849.29
 归属于少数股东的其他综合收益(元) -0.04-0.010.030.01-0.02
九、综合收益总额(元) 71,475,526.5730,991,471.7262,257,317.8730,088,935.488,819,319.51
 归属于母公司所有者的综合收益总额(元) 72,220,827.6731,072,962.3662,236,742.8830,280,576.838,972,174.34
 归属于少数股东的综合收益总额(元) -745,301.10-81,490.6420,574.99-191,641.35-152,854.83
公告日期 2024-04-222023-08-232023-04-212022-08-242022-04-28
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院